Cancer clinical trials in the region Pays de la Loire

236 currently recruiting clinical trials
Region Pays de la Loire

Phase 3 Colon cancer Rectal cancer #NCT06662786
Locally Advanced Metastatic None Systemic Treatment-Naive
BRAF HER2 KRAS G12C KRAS non G12C MSI/dMMR NRAS
Centre Hospitalier Universitaire de Nantes (Nantes)
Janssen
Phase 3 Lung cancer #NCT06422143
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Metastatic None Systemic Treatment-Naive
Immunotherapy Antibody Drug Conjugates (ADC) Immunotherapy Antibody Drug Conjugates (ADC)
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Merck Sharp & Dohme LLC
Phase 3 Lung cancer #NCT06635824
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 Immunotherapy Chemotherapy
ALK BRAF EGFR KRAS G12C KRAS non G12C MET RET ROS-1 Systemic Treatment-Naive Car-T
Hôpital Privé du Confluent - Vivalto Santé (Nantes), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Angers (Angers )
Genmab
Phase 3 CLL & Richter's syndrome #NCT05947851
CLL (Chronic Lymphocytic Leukemia) None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Merck Sharp & Dohme LLC
Phase 3 Breast cancer #NCT06435429
HER2 Positive Locally Advanced Metastatic 1 2 3 or more Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Centre de Cancerologie de la Sarthe (Le Mans)
Jazz Pharmaceuticals
Phase 3 Kidney cancer #NCT06364631
Clear cell carcinoma Metastatic None 0 1 or 2 Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Lung cancer #NCT06472245
NSCLC (Non-Small Cell Lung Cancer) Metastatic Immunotherapy
ALK EGFR ROS-1
Centre Hospitalier de Cholet (Cholet), Centre Hospitalier Universitaire de Nantes (Nantes), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier du Mans (Le Mans), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
OSE Immunotherapeutics
Phase 3 Lung cancer #NCT06140836
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ROS-1 None 1
ALK BRAF EGFR HER2 KRAS G12C KRAS non G12C MET NTRK-1/2/3 RET PIK3CA Targeted therapy Targeted therapy
Centre Hospitalier Universitaire Laennec (Saint-Herblain)
Bristol-Myers Squibb
Phase 3 Lung cancer #NCT06077760
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Localized Locally Advanced None Surgery Surgery
Immunotherapy Immunotherapy
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers )
Merck Sharp & Dohme LLC
Phase 3 Liver and bile duct cancer #NCT05876754
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic IDH1/2 1 2 3 or more
Transplant Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes)
Servier